The NIH’s All of Us Research Program expanded its database into multiomics, adding RNA sequencing and proteomics data for nearly 750,000 participants. The expansion broadens the precision-health resource from single-layer biology toward more integrated molecular readouts, aimed at supporting deeper cohort discovery and mechanism-driven research. All of Us continues to function as a large, diverse research dataset, and the multiomics layer is designed to improve how investigators study disease trajectories, treatment response, and biomarker discovery across varied populations. For biotech and pharma teams, the additional omics breadth can accelerate target validation and translational work by supporting hypothesis generation from molecular signatures rather than relying only on clinical variables.